Kaneko Y, Okita H, Haruta M, Arai Y, Oue T, Tanaka Y, Horie H, Hinotsu S, Koshinaga T, Yoneda A, Ohtsuka Y, Taguchi T, Fukuzawa M
1] Department of Cancer Diagnosis, Research Institute for Clinical Oncology, Saitama Cancer Center, Ina, Saitama 362-0806, Japan [2] Japan Wilms Tumor Study Group (JWiTS), Itabashi-Ku, Tokyo 173-8610, Japan.
Japan Wilms Tumor Study Group (JWiTS), Itabashi-Ku, Tokyo 173-8610, Japan.
Br J Cancer. 2015 Mar 17;112(6):1121-33. doi: 10.1038/bjc.2015.13.
Bilateral Wilms tumours (BWTs) occur by germline mutation of various predisposing genes; one of which is WT1 whose abnormality was reported in 17-38% of BWTs in Caucasians, whereas no such studies have been conducted in East-Asians. Carriers with WT1 mutations are increasing because of improved survival.
Statuses of WT1 and IGF2 were examined in 45 BWTs from 31 patients with WT1 sequencing and SNP array-based genomic analyses. The penetrance rates were estimated in WT1-mutant familial Wilms tumours collected from the present and previous studies.
We detected WT1 abnormalities in 25 (81%) of 31 patients and two families, which were included in the penetrance rate analysis of familial Wilms tumour. Of 35 BWTs from the 25 patients, 31 had small homozygous WT1 mutations and uniparental disomy of IGF2, while 4 had large 11p13 deletions with the retention of 11p heterozygosity. The penetrance rate was 100% if children inherited small WT1 mutations from their fathers, and 67% if inherited the mutations from their mothers, or inherited or had de novo 11p13 deletions irrespective of parental origin (P=0.057).
The high incidence of WT1 abnormalities in Japanese BWTs sharply contrasts with the lower incidence in Caucasian counterparts, and the penetrance rates should be clarified for genetic counselling of survivors with WT1 mutations.
双侧肾母细胞瘤(BWT)由多种易感基因的种系突变引起;其中之一是WT1,在白种人中,17%-38%的BWT报告有该基因异常,而东亚人群尚未开展此类研究。由于生存率提高,携带WT1突变的患者数量在增加。
对31例患者的45个BWT进行WT1和IGF2检测,采用WT1测序和基于单核苷酸多态性(SNP)阵列的基因组分析。从本研究和既往研究中收集WT1突变型家族性肾母细胞瘤,估计其外显率。
我们在31例患者中的25例(81%)以及两个家族中检测到WT1异常,这些被纳入家族性肾母细胞瘤外显率分析。在这25例患者的35个BWT中,31个有小的纯合WT1突变和IGF2单亲二倍体,4个有11p13大片段缺失且保留11p杂合性。如果儿童从父亲遗传小的WT1突变,外显率为100%;如果从母亲遗传突变,或遗传或新发11p13缺失(无论亲本来源),外显率为67%(P=0.057)。
日本BWT中WT1异常的高发生率与白种人较低的发生率形成鲜明对比,对于携带WT1突变的幸存者进行遗传咨询时,应明确外显率。